Search
for
Sort by
Research 511–540 of 568
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
- Female pattern hair loss
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Drug-Induced Skin, Nail and Hair Disorders
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Folliculitis
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- An Update on Drug-Induced Pigmentation
- Case 21-2012
- Urinary steroids in women with androgenic alopecia
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Rational investigations in the diagnosis and management of women with hirsutism or androgenetic alopecia
- A study on the clinical and hormonal profile of patients with hirsutism
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Physiological perspective of Hirsutism in Unani Medicine: An Overview and Update
- Hirsutism in Jordanian Women
- Systemic Corticosteroids in Vitiligo
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin®, on the healing of skin wound
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
- Alopecia and Hirsuties
- Focal and Generalized Alopecia
- Diseases of the skin. Treatment of scalp disorders.
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities